The decline in Nu Skin is due to the power of one word: Innuendo.
The letter did not recognize, however, the existing research relationship between Nu Skin and Stanford.
Nu Skin has stopped imports of the Galvanic Spa facial unit pending resolution of this matter.
The Department of Dermatology in the Stanford School of Medicine has had a long-standing research-based relationship with Nu Skin Enterprises.
If registration is required, Nu Skin believes it could receive clearance from the FDA in the next six to nine months.
Nevertheless, those reports, justified or not, have already done their job of making nervous investors even more jittery about buying shares of Nu Skin.
Researchers in the department currently have one on-going study funded by Nu Skin related to the identification of master regulators and epigenetic changes to human skin aging.
However, another company called Pharmanex , a subsidiary of Nu Skin Enterprises nus (nyse: nus - news - people), peddles the same compound under the brand name Cholestin.
He thinks it should be more like Nu Skin Enterprises, a rival that pays its sales force not only for their own sales but also for the sales of others they recruit.
This was initially triggered by two scathing reports based on limited and obvious data mined research by Citron Research, an outfit with a likely monetary interest in seeing shares of Nu Skin fall.
Citron publishes two highly critical reports accusing Nu Skin of running an illegal pyramid scheme in China within days of each other, then, aside from a sorry excuse of a letter, does nothing for basically three months.
Among the largest underlying components of IWO, in trading today Clean Harbors, Inc ( NYSE: CLH) is up about 0.4%, Rosetta Resources, Inc. ( NASD: ROSE) is off about 1.3%, and NU Skin Enterprises, Inc. ( NYSE: NUS) is higher by about 0.5%.
Among the largest underlying components of IWO, in trading today Netlogic Microsystems Incorporated ( NASD: NETL) is down about 0.1%, Home Properties Incorporated ( NYSE: HME) is off about 0.2%, and NU Skin Enterprises Incorporated ( NYSE: NUS) is lower by about 1.1%.
Shares of Nu Skin (NUS) Enterprises have been hammered over the past ten days after Citron Research released two reports accusing the company of perpetrating illegal marketing tactics in China, violating FDA regulatory law and deceptively associating themselves with the highly-regarded Stanford University.
应用推荐